Non-withdrawal of beta-blockers in acute decompensated chronic and de-novo heart failure is associated with lower in-hospital and 3-months mortality: Findings from the GULF-CARE
Beta-blockers, ACE/ARB and MRA at discharge and outcome after hospitalization of heart failure in octogenarians with HFPEF and HFREF: a report from the BIO-HF registry
Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure
Speaker:
Associate Professor T. Ichiki (Rochester, US)